Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-16-009281
Filing Date
2016-04-20
Accepted
2016-04-20 16:05:13
Documents
4
Period of Report
2016-06-01
Effectiveness Date
2016-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042016.htm DEF 14A 403818
2 GRAPHIC cheung.jpg GRAPHIC 2449
3 GRAPHIC proxycard_1.jpg GRAPHIC 183144
4 GRAPHIC proxycard_2.jpg GRAPHIC 203481
  Complete submission text file 0001171843-16-009281.txt   941206
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14027 | Film No.: 161581412
SIC: 3841 Surgical & Medical Instruments & Apparatus